CORONA, Calif., Feb. 5 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the company expects to initiate shipments of alendronate sodium in ...

Women who have ever used alendronate sodium may be at an increased risk of incident atrial fibrillation, according to recent data published in the Archives of Internal Medicine. Researchers from ...

The US Food and Drug Administration has granted tentative approval for Teva Pharmaceutical Industries’s ANDA for Alendronate Sodium Tablets, 5 milograms (mg), 10 mg, 35 mg, 40 mg and 70 mg.

BANGALORE, Sept 12 (Reuters) - India's Sun Pharmaceutical Industries said it has received approval from the U.S. Food and Drug Administration to market alendronate sodium tablets, the generic version ...

This drug had not previously been considered by the PBAC for this indication. Osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific ...

Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Fosamax. Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Merck‘s ...

BINOSTO (alendronate sodium) 70mg effervescent tablet for oral solution by Mission Pharmacal Mission Pharmacal Company announced that Binosto (alendronate sodium) effervescent tablet for buffered oral ...

In this analysis, 3 bisphosphonates (alendronate, pamidronate, and zoledronic acid) and 1 RANK ligand inhibitor (denosumab) were evaluated for their effectiveness at preventing osteoclasts from ...

FREIENBACH, Switzerland — The Food and Drug Administration approved an effervescent tablet for treating osteoporosis. EffRx Pharmaceuticals announced the FDA approval of Binosto (alendronate sodium), ...

WHITEHOUSE STATION, N.J., November 23, 2009 - Merck said today that U.S. District Court Judge John F. Keenan granted summary judgment in Merck's favor in Flemings v. Merck. Flemings is the second of ...